Regional convection-enhanced delivery of gadolinium-labeled albumin in the rat hippocampus in vivo

Journal of Neuroscience Methods

Volumn 187, Issue 1, 2010, Pages 129-137

  Astary, Garrett W ^a   Kantorovich, Svetlana ^b   Carney, Paul R ^a,b,c   Mareci, Thomas H ^c   Sarntinoranont, Malisa ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Contrast agent; Convection enhanced delivery; Gd albumin; Magnetic resonance imaging; Rat hippocampus

Indexed keywords

EVANS BLUE; GADOLINIUM PENTETATE ALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; DENTATE GYRUS; FLUORESCENCE IMAGING; HIPPOCAMPUS; HISTOPATHOLOGY; IMAGE ANALYSIS; IN VIVO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; TISSUE DISTRIBUTION;

ALBUMINS; ANIMALS; CA1 REGION, HIPPOCAMPAL; CONTRAST MEDIA; DENTATE GYRUS; DERMOSCOPY; DIFFUSION; DRUG DELIVERY SYSTEMS; FLUORESCENCE; GADOLINIUM DTPA; HIPPOCAMPUS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; NEURONS; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77249121575     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2010.01.002     Document Type: Article

References (52)

1. Abujudeh H.H., Kaewlai R., Kagan A., Chibnik L.B., Nazarian R.M., High W.A., et al. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients. Radiology 2009, 253:81-89.
2. Andersen A.H. On the Rician distribution of noisy MRI data. Magn Reson Med 1996, 36:331-333.
3. Andersen P., Bliss T.V., Lomo T., Olsen L.I., Skrede K.K. Lamellar organization of hippocampal excitatory pathways. Acta Physiol Scand 1969, 76:4A-5A.
4. Auer R.N., Siesjo B.K. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 1988, 24:699-707.
5. Bertram E.H. Temporal lobe epilepsy: where do the seizures really begin?. Epilepsy Behav 2009, 14(Suppl. 1):32-37.
6. Burtea C., Laurent S., Vander Elst L., Muller R.N. Contrast agents: magnetic resonance. Handb Exp Pharmacol 2008, 135-165.
7. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99:2293-2352.
8. Chen X., Astary G.W., Sepulveda H., Mareci T.H., Sarntinoranont M. Quantitative assessment of macromolecular concentration during direct infusion into an agarose hydrogel phantom using contrast-enhanced MRI. Magn Reson Imaging 2008.
9. Corsellis J.A., Goldberg G.J., Norton A.R. " Limbic encephalitis" and its association with carcinoma. Brain 1968, 91:481-496.
10. deToledo-Morrell L., Stoub T.R., Wang C. Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease. Prog Brain Res 2007, 163:741-753.
11. Dickson D.W., Davies P., Bevona C., Van Hoeven K.H., Factor S.M., Grober E., et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or =80 years of age) humans. Acta Neuropathol 1994, 88:212-221.
12. Ding D., Kanaly C.W., Bigner D.D., Cummings T.J., Herndon J.E., Pastan I., et al. Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. J Neurooncol 2009.
13. Dolorfo C.L., Amaral D.G. Entorhinal cortex of the rat: topographic organization of the cells of origin of the perforant path projection to the dentate gyrus. J Comp Neurol 1998, 398:25-48.
14. Duyckaerts C., Panchal M., Delatour B., Potier M.C. Morphologic and molecular neuropathology of Alzheimer's disease. Ann Pharm Fr 2009, 67:127-135.
15. Esclassan F., Coutureau E., Di Scala G., Marchand A.R. Differential contribution of dorsal and ventral hippocampus to trace and delay fear conditioning. Hippocampus 2009, 19:33-44.
16. Fiandaca M.S., Forsayeth J.R., Dickinson P.J., Bankiewicz K.S. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 2008, 5:123-127.
17. Foley C.P., Nishimura N., Neeves K.B., Schaffer C.B., Olbricht W.L. Flexible microfluidic devices supported by biodegradable insertion scaffolds for convection-enhanced neural drug delivery. Biomed Microdev 2009.
18. Fricke R., Cowan W.M. An autoradiographic study of the commissural and ipsilateral hippocampo-dentate projections in the adult rat. J Comp Neurol 1978, 181:253-269.
19. Goldberg L., Ocherashvilli A., Daniels D., Last D., Cohen Z.R., Tamar G., et al. Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats. Mol Cancer Ther 2008, 7:3609-3616.
20. Haring J.H., Davis J.N. Differential distribution of locus coeruleus projections to the hippocampal formation: anatomical and biochemical evidence. Brain Res 1985, 325:366-369.
21. Heiss J.D., Walbridge S., Morrison P., Hampton R.R., Sato S., Vortmeyer A., et al. Local distribution and toxicity of prolonged hippocampal infusion of muscimol. J Neurosurg 2005, 103:1035-1045.
22. Humphrey T. The development of the human hippocampal fissure. J Anat 1967, 101:655-676.
23. Ishizuka N., Weber J., Amaral D.G. Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J Comp Neurol 1990, 295:580-623.
24. Jagannathan J., Walbridge S., Butman J.A., Oldfield E.H., Lonser R.R. Effect of ependymal and pial surfaces on convection-enhanced delivery. J Neurosurg 2008, 109:547-552.
25. Jung M.W., Wiener S.I., McNaughton B.L. Comparison of spatial firing characteristics of units in dorsal and ventral hippocampus of the rat. J Neurosci 1994, 14:7347-7356.
26. Kikuchi T., Saito R., Sugiyama S., Yamashita Y., Kumabe T., Krauze M., et al. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models. J Neurosurg 2008, 109:867-873.
27. Koay C.G., Basser P.J. Analytically exact correction scheme for signal extraction from noisy magnitude MR signals. J Magn Reson 2006, 179:317-322.
28. Krauze M.T., Saito R., Noble C., Tamas M., Bringas J., Park J.W., et al. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 2005, 103:923-929.
29. Krauze M.T., Vandenberg S.R., Yamashita Y., Saito R., Forsayeth J., Noble C., et al. Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Exp Neurol 2008, 210:638-644.
30. Krettek J.E., Price J.L. Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat. J Comp Neurol 1977, 172:723-752.
31. Lauffer R.B. Paramagnetic Metal-complexes as water proton relaxation agents for NMR imaging-theory and design. Chem Rev 1987, 87:901-927.
32. Li X.G., Somogyi P., Ylinen A., Buzsaki G. The hippocampal CA3 network: an in vivo intracellular labeling study. J Comp Neurol 1994, 339:181-208.
33. Maier M., Ron M.A., Barker G.J., Tofts P.S. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol Med 1995, 25:1201-1209.
34. Mamot C., Nguyen J.B., Pourdehnad M., Hadaczek P., Saito R., Bringas J.R., et al. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol 2004, 68:1-9.
35. Mardor Y., Last D., Daniels D., Shneor R., Maier S.E., Nass D., et al. Convection-enhanced drug delivery of interleukin-4 pseudomonas exotoxin (PRX321): increased distribution and magnetic resonance monitoring. J Pharmacol Exp Ther 2009, 330:520-525.
36. Mardor Y., Rahav O., Zauberman Y., Lidar Z., Ocherashvilli A., Daniels D., et al. Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res 2005, 65:6858-6863.
37. Mazel T., Simonova Z., Sykova E. Diffusion heterogeneity and anisotropy in rat hippocampus. Neuroreport 1998, 9:1299-1304.
38. Morrison P.F., Chen M.Y., Chadwick R.S., Lonser R.R., Oldfield E.H. Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Phys Reg Integr Comp Physiol 1999, 277:R1218-R1229.
39. Moser E., Moser M.B., Andersen P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J Neurosci 1993, 13:3916-3925.
40. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998, 55:433-440.
41. Ohm T.G. The dentate gyrus in Alzheimer's disease. Prog Brain Res 2007, 163:723-740.
42. Olson J.J., Zhang Z., Dillehay D., Stubbs J. Assessment of a balloon-tipped catheter modified for intracerebral convection-enhanced delivery. J Neurooncol 2008, 89:159-168.
43. Paxinos G., Watson C. The rat brain in sterotaxic coordinates 1998, Academic Press, San Diego. 4th ed.
44. Perlstein B., Ram Z., Daniels D., Ocherashvilli A., Roth Y., Margel S., et al. Convection-enhanced delivery of maghemite nanoparticles: increased efficacy and MRI monitoring. Neurooncology 2008, 10:153-161.
45. Raghavan R., Brady M.L., Rodriguez-Ponce M.I., Hartlep A., Pedain C., Sampson J.H. Convection-enhanced delivery of therapeutics for brain disease, and its optimization. Neurosurg Focus 2006, 20:E12.
46. Rogawski M.A. Convection-enhanced delivery in the treatment of epilepsy. Neurotherapeutics 2009, 6:344-351.
47. Sampson J.H., Brady M.L., Petry N.A., Croteau D., Friedman A.H., Friedman H.S., et al. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. Neurosurgery 2007, 60. ONS89-98; discussion ONS-9.
48. Song D.K., Lonser R.R. Convection-enhanced delivery for the treatment of pediatric neurologic disorders. J Child Neurol 2008, 23:1231-1237.
49. Sykova E., Nicholson C. Diffusion in brain extracellular space. Physiol Rev 2008, 88:1277-1340.
50. Tao L., Nicholson C. Diffusion of albumins in rat cortical slices and relevance to volume transmission. Neuroscience 1996, 75:839-847.
51. Tate D.F., Bigler E.D. Fornix and hippocampal atrophy in traumatic brain injury. Learn Mem 2000, 7:442-446.
52. Verney C., Baulac M., Berger B., Alvarez C., Vigny A., Helle K.B. Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience 1985, 14:1039-1052.